Advances in traditional Chinese medicine for cardiovascular disease therapy in 2020

Journal Title: Traditional Medicine Research - Year 2021, Vol 6, Issue 3

Abstract

Cardiovascular diseases are a major cause of morbidity and mortality worldwide and there is an urgent need to develop new pharmacotherapies for managing cardiovascular diseases. In China, traditional Chinese medicine has been used in clinical settings for thousands of years. Although traditional Chinese medicine is very popular, Western medicine experts have not yet accepted it because some ingredients and mechanisms of action for its therapeutic effect are not fully clear. Emerging evidence has established that traditional Chinese medicine inhibits oxidative stress and inflammatory response, suppresses apoptosis, promotes angiogenesis, regulates autophagy and gut microbiota, and modulates metabolomics, among others. Therefore, it has a beneficial role against cardiovascular disease occurrence and progression, such as atherosclerosis, hypertension, myocardial ischemia/reperfusion injury, myocardial infarction, cardiomyopathy, arrhythmia, cardiac remodeling, pulmonary arterial hypertension, and heart failure. In this review, we have summarized the research progress on the relevant mechanisms by which traditional Chinese medicine regulates cardiovascular diseases in 2020 to reveal its application to cardiovascular disease prevention and/or therapy.

Authors and Affiliations

Kun Xiang, Jin-Fu Yang, Xun Wu, Jun Peng, Jian-Jun Guo, Cheng-Ming Fan

Keywords

Related Articles

The effect of acupuncture plus drug versus drug alone on patients with mild cognitive impairment: a systematic review

Objective:The aim of this systematic review is to evaluate the effect of acupuncture plus drug versus drug alone on patients with MCI.Methods:A computerized search of the databaseswas performed from inception through Feb...

Tu Youyou:A scientist moving forward in controversy

The 13th National People's Congress Standing Committee was held in Beijing on Sept. 17, 2019. President of China Xi Jinping signed a presidential decree to award individuals, national medals and honorary titles. Tu Youyo...

The neuroprotective role of Panax notoginseng saponins in APP/PS1 transgenic mice through the modulation of cerebrovascular

Background: Panax notoginseng saponins (PNS) is extracted from Sanqi (Panax notoginseng), which is a valuable herb and has been widely used in traditional Chinese medicine for the treatment of cerebrovascular diseases an...

Network pharmacology-based approach to investigate the mechanism of Huang-Lian-Jie-Du-Decoction for treatment of type 2 diabetes mellitus

Background: Although the benefits of Huang-Lian-Jie-Du-Decoction (HLJDD) on type 2 diabetes mellitus are noted, the material base and action mechanism remain unknown. This paper aim is to reveal the material base and act...

Investigation of the processing technology and mechanism of Kansui radix by licorice based on response surface methodology and integrative pharmacology

Background: The herbs should be processed by different methods before use, and the efficacy and toxicity of Chinese herbal medicines may change, which may enhance efficacy and reduce toxicity after processing. Gansui (Ka...

Download PDF file
  • EP ID EP693635
  • DOI 10.12032/TMR20210318226
  • Views 123
  • Downloads 0

How To Cite

Kun Xiang, Jin-Fu Yang, Xun Wu, Jun Peng, Jian-Jun Guo, Cheng-Ming Fan (2021). Advances in traditional Chinese medicine for cardiovascular disease therapy in 2020. Traditional Medicine Research, 6(3), -. https://europub.co.uk/articles/-A-693635